Stop guessing. LongevityOS analyzes your age, health goals, and budget β then generates a ranked, evidence-based protocol from Tier 1 clinical interventions to cutting-edge experimental options.
Age, sex, current health status, existing supplements, monthly budget. Takes 60 seconds.
Our model cross-references clinical trials, meta-analyses, and expert protocols to rank interventions by your specific profile.
Evidence tier, cost breakdown, dosing schedule, and drug interaction warnings β all in plain language.
Log your biomarkers. LongevityOS adjusts your protocol as science advances and your data changes.
We use a 3-tier evidence framework. Tier 1 interventions have strong clinical backing. We never mix proven and experimental in the same priority bucket.
Fill in your profile and get a sample protocol instantly. Full personalization available on paid plans.
β οΈ This is educational information, not medical advice. Consult your physician before starting any new protocol.
Life Biosciences ER-100: first-ever cellular rejuvenation therapy using partial epigenetic reprogramming in humans. Targets vision loss. Nat Biotechnol 44:164 (2026).
Comprehensive review: NMN/NR reliably raise blood NAD+ but show "functional ambiguity" β no robust human aging outcome improvements. Biomarker success β healthspan benefit.
Dasatinib + Quercetin clears highly resistant senescent cells without serious side effects. Phase I Alzheimer's trial shows safety at 2-day/month protocol. Muscle function improvements confirmed across multiple groups.
PPARΞ± agonist fenofibrate (generic, ~$20/mo) delays aging progression and reverses cellular senescence in mice. Attenuates lipid accumulation and mitochondrial dysfunction. Human aging trials pending.
New gene therapy targeting cellular stress response restores memory function in aged mice. Mechanism involves ANKRD1 protein and neurological rejuvenation pathways.
Depleting aged gut microbiome reversed aspects of brain aging. Aged microbiome produces inflammatory signals disrupting neurogenesis β pointing to FMT and targeted probiotic interventions as undervalued cognitive aging tools.
Beyond weight loss: Ozempic/Wegovy showing cardiovascular, neurological, and metabolic protection far beyond their original indication. Potential senolytic-adjacent mechanisms under investigation.
Perfect for exploring what's possible
Full personalization + ongoing updates
Deep personalization + concierge support
No. LongevityOS provides evidence-ranked educational information based on published research. Always consult your physician before starting any new supplement, medication, or health protocol β especially prescription interventions like rapamycin or metformin.
Google gives you 10,000 contradictory articles. LongevityOS synthesizes 400+ peer-reviewed studies, weights them by evidence quality, and filters by YOUR specific age, goals, budget, and health conditions. You get a ranked action list β not a research rabbit hole.
Monthly. When significant trials publish (like the Life Biosciences FDA clearance), we update within days. Pro users get instant alerts.
Our Pro tier includes a drug interaction checker. For example: metformin + B12 depletion warning, rapamycin + immunosuppression cautions, and NMN + cancer risk nuances are all flagged.
Yes β and we encourage it. Pro users can export a PDF of their protocol to share with their physician. More doctors are familiar with longevity medicine every year.